ZURICH, Nov 20 (Reuters) - Teva Pharmaceutical Industries Ltd:
* Europe drugs agency says not recommending nenad from axxonis pharma for
restless legs syndrome
* Europe drugs agency recommends three generics from Teva, docetaxel Teva,
telmisartan Teva and temozolomide Teva
((Zurich Newsroom, zurich.newsroom@reuters.com, +41 58 306 7336))
(For more information, click on http://www.emea.europa.eu/pdfs/human/press/pr/75243109en.pdf) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Europe drugs agency says not recommending nenad from axxonis pharma for
restless legs syndrome
* Europe drugs agency recommends three generics from Teva, docetaxel Teva,
telmisartan Teva and temozolomide Teva
((Zurich Newsroom, zurich.newsroom@reuters.com, +41 58 306 7336))
(For more information, click on http://www.emea.europa.eu/pdfs/human/press/pr/75243109en.pdf) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
